Full bibliography
Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies
Resource type
Authors/contributors
- Miller, Jennifer E (Author)
- Wilenzick, Marc (Author)
- Ritcey, Nolan (Author)
- Ross, Joseph S (Author)
- Mello, Michelle M (Author)
Title
Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies
Abstract
Summary. Describes how commonly drug companies fail to adhere to obligations to disclose clinical trial results. My collaboration with Dr. Miller is a direct result of my Safra fellowship.
Publication
BMJ Open
Volume
7
Issue
12
Pages
e017917
Date
12/2017
Journal Abbr
BMJ Open
Language
en
DOI
10.1136/bmjopen-2017-017917
ISSN
2044-6055, 2044-6055
Short Title
Measuring clinical trial transparency
Accessed
9/14/20, 7:32 PM
Library Catalog
DOI.org (Crossref)
Citation
Miller, J. E., Wilenzick, M., Ritcey, N., Ross, J. S., & Mello, M. M. (2017). Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies. BMJ Open, 7(12), e017917. https://doi.org/10.1136/bmjopen-2017-017917
Link to this record